| 12497382 |
GLP-1R modulating compounds |
Stephen E. Ammann, Gediminas Brizgys, James S. Cassidy, Elbert Chin, Charles C. Chou +12 more |
2025-12-16 |
|
| 12247032 |
Substituted pyrazolo[1,5-a]pyrimidines as inhibitors of JAK kinases |
Mark Edward Zak, Naomi Rajapaksa, Yun-Xing Cheng, Jessica Grandner, F. Anthony Romero +1 more |
2025-03-11 |
|
| 12121511 |
GLP-1R modulating compounds |
Stephen E. Ammann, Gediminas Brizgys, James S. Cassidy, Elbert Chin, Chienhung Chou +8 more |
2024-10-22 |
$144,823,000 |
| 12070455 |
Thienopyrrole compounds |
Stephen E. Ammann, Eda Canales, Weng K. Chang, Henok H. Kinfe, Scott E. Lazerwith +3 more |
2024-08-27 |
$638,061,000 |
| 11702404 |
GLP-1R modulating compounds |
Stephen E. Ammann, Gediminas Brizgys, James S. Cassidy, Elbert Chin, Chienhung Chou +12 more |
2023-07-18 |
$149,671,000 |
| 11661431 |
Thienopyrrole compounds |
Stephen E. Ammann, Eda Canales, Weng K. Chang, Henok H. Kinfe, Scott E. Lazerwith +4 more |
2023-05-30 |
$275,933,000 |
| 11453671 |
Pyrazolopyrimidine inhibitors of JAK kinases and uses thereof |
Mark Edward Zak, Naomi Rajapaksa, Yun-Xing Cheng, Jessica Grandner, Marian C. Bryan |
2022-09-27 |
|
| 11236046 |
Substituted heterocyclic sulfonamide compounds useful as TRPA1 modulators |
Huifen Chen, Yanyan Chu, Steven Do, Anthony A. Estrada, Baihua Hu +7 more |
2022-02-01 |
|
| 11129832 |
Biheteroaryl compounds and uses thereof |
Anthony Estrada, Liting Dong, Kevin X. Chen, Paul Gibbons, Malcolm Huestis +7 more |
2021-09-28 |
|
| 10913742 |
Oxadiazolones as transient receptor potential channel inhibitors |
Huifen Chen, Elisia Villemure, Matthew Volgraf, Baihua Hu, Aijun Lu +5 more |
2021-02-09 |
|
| 10711004 |
Oxadiazole transient receptor potential channel inhibitors |
Huifen Chen, Brian Safina, Jack Terrett, Elisia Villemure, Matthew Volgraf +8 more |
2020-07-14 |
|
| 10597383 |
Bicyclic proline compounds |
Vishal Verma, Matthew Volgraf, Anthony A. Estrada, Joseph P. Lyssikatos |
2020-03-24 |
|
| 10179782 |
Substituted sulfonamide compounds |
Anthony A. Estrada, Elisia Villemure, Vishal Verma, Matthew Volgraf, Baihua Hu +1 more |
2019-01-15 |
|
| 10131675 |
Tricyclic DLK inhibitors and uses thereof |
Anthony Estrada, Snahel Patel, Terry Kellar, Malcolm Huestis, Michael Siu |
2018-11-20 |
|
| 10010549 |
Biheteroaryl compounds and uses thereof |
Anthony Estrada, Liting Dong, Kevin X. Chen, Paul Gibbons, Malcolm Huestis +7 more |
2018-07-03 |
|
| 9145402 |
Aminopyrimidine derivatives as LRRK2 modulators |
Charles Baker-Glenn, Mark Stuart Chambers, Bryan Chan, Anthony A. Estrada, Zachary K. Sweeney +1 more |
2015-09-29 |
|
| 8809331 |
Aminopyrimidine derivatives as LRRK2 modulators |
Charles Baker-Glenn, Daniel J. Burdick, Mark Stuart Chambers, Bryan Chan, Huifen Chen +5 more |
2014-08-19 |
|
| 8802674 |
Aminopyrimidine derivatives as LRRK2 modulators |
Charles Baker-Glenn, Daniel J. Burdick, Mark Stuart Chambers, Bryan Chan, Huifen Chen +5 more |
2014-08-12 |
|
| 8569281 |
Compounds and their administration for treating a neurodegenerative disease as well as a method for identifying a compound capable of inhibiting a kinase, such as LRRK |
Bryan Chan, Huifen Chen, Anthony A. Estrada, Zachary K. Sweeney, Edward Giles Mciver |
2013-10-29 |
|
| 8354420 |
Aminopyrimidine derivatives as LRRK2 inhibitors |
Charles Baker-Glenn, Daniel J. Burdick, Mark Stuart Chambers, Bryan Chan, Huifen Chen +5 more |
2013-01-15 |
|
